Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v9-FR | Version v8-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-03-20 | 2024-03-20 |
| Drug Identification Number | 02448599 | 02448599 |
| Brand name | TRULICITY | TRULICITY |
| Common or Proper name | dulaglutide | dulaglutide |
| Company Name | ELI LILLY CANADA INC | ELI LILLY CANADA INC |
| Ingredients | DULAGLUTIDE | DULAGLUTIDE |
| Strength(s) | 0.75MG | 0.75MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 4 x 0.5 mL single-use prefilled pen | 4 x 0.5 mL single-use prefilled pen |
| ATC code | A10BJ | A10BJ |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2023-11-30 | 2023-11-30 |
| Actual start date | 2023-11-30 | 2023-11-30 |
| Estimated end date | 2024-05-31 | 2024-05-31 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Due to continued demand an allocation strategy has been implemented. The estimated end date represents projected availability at the main Lilly warehouse. Availability dates at a pharmacy’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their distributor to obtain the product availability date at the distributor, or to contact our Lilly Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays) for more information. | Due to continued demand an allocation strategy has been implemented. The estimated end date represents projected availability at the main Lilly warehouse. Availability dates at a pharmacy’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their distributor to obtain the product availability date at the distributor, or to contact our Lilly Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays) for more information. |
| Health Canada comments |